175 related articles for article (PubMed ID: 30074662)
1. Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
Boselli E; Jacquet-Lagrèze M; Ayoub JY; Bouvet L; Dauwalder O; Mansour C; Margez T; Paquet C; Restagno D; Allaouchiche B; Bonnet-Garin JM; Junot S
J Vet Emerg Crit Care (San Antonio); 2018 Sep; 28(5):447-456. PubMed ID: 30074662
[TBL] [Abstract][Full Text] [Related]
2. Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model.
Jacquet-Lagrèze M; Allaouchiche B; Restagno D; Paquet C; Ayoub JY; Etienne J; Vandenesch F; Dauwalder O; Bonnet JM; Junot S
Crit Care; 2015 Jun; 19(1):241. PubMed ID: 26041462
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.
Levy B; Fritz C; Piona C; Duarte K; Morelli A; Guerci P; Kimmoun A; Girerd N
Crit Care; 2021 Jan; 25(1):21. PubMed ID: 33413583
[TBL] [Abstract][Full Text] [Related]
4. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock.
Aboab J; Sebille V; Jourdain M; Mangalaboyi J; Gharbi M; Mansart A; Annane D
Intensive Care Med; 2011 Aug; 37(8):1344-51. PubMed ID: 21567116
[TBL] [Abstract][Full Text] [Related]
5. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
[TBL] [Abstract][Full Text] [Related]
6. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
Morelli A; Singer M; Ranieri VM; D'Egidio A; Mascia L; Orecchioni A; Piscioneri F; Guarracino F; Greco E; Peruzzi M; Biondi-Zoccai G; Frati G; Romano SM
Intensive Care Med; 2016 Oct; 42(10):1528-1534. PubMed ID: 27101380
[TBL] [Abstract][Full Text] [Related]
7. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
[TBL] [Abstract][Full Text] [Related]
8. Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock.
Hernández G; Tapia P; Alegría L; Soto D; Luengo C; Gomez J; Jarufe N; Achurra P; Rebolledo R; Bruhn A; Castro R; Kattan E; Ospina-Tascón G; Bakker J
Crit Care; 2016 Aug; 20(1):234. PubMed ID: 27480413
[TBL] [Abstract][Full Text] [Related]
9. [Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate].
Xinqiang L; Weiping H; Miaoyun W; Wenxin Z; Wenqiang J; Shenglong C; Juhao Z; Hongki Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):759-63. PubMed ID: 26955704
[TBL] [Abstract][Full Text] [Related]
10. Esmolol Administration to Control Tachycardia in an Ovine Model of Peritonitis.
Hosokawa K; Su F; Taccone FS; Post EH; Pereira AJ; Herpain A; Creteur J; Vincent JL
Anesth Analg; 2017 Dec; 125(6):1952-1959. PubMed ID: 28708664
[TBL] [Abstract][Full Text] [Related]
11. Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.
Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; D'Egidio A; Cecchini V; Landoni G; Pietropaoli P; Westphal M; Venditti M; Mebazaa A; Singer M
Crit Care Med; 2013 Sep; 41(9):2162-8. PubMed ID: 23873274
[TBL] [Abstract][Full Text] [Related]
12. [Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].
Tao Y; Jingyi W; Xiaogan J; Weihua L; Xiaoju J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):885-9. PubMed ID: 27132454
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
Du W; Wang XT; Long Y; Liu DW
Chin Med J (Engl); 2016 Jul; 129(14):1658-65. PubMed ID: 27411452
[TBL] [Abstract][Full Text] [Related]
14. [Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
Yang S; Liu Z; Yang W; Zhang G; Hou B; Liu J; Shi Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):714-7. PubMed ID: 25315942
[TBL] [Abstract][Full Text] [Related]
15. [Effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients].
Chen JX; Sun J; Liu YY; Jia BH
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(16):1243-6. PubMed ID: 23902616
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Wang Z; Wu Q; Nie X; Guo J; Yang C
Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
[TBL] [Abstract][Full Text] [Related]
17. Esmolol for septic shock: more than just heart rate control?
Orbegozo Cortes D; Njimi H; Dell'Anna AM; Taccone FS
Minerva Anestesiol; 2014 Feb; 80(2):254-8. PubMed ID: 24500140
[TBL] [Abstract][Full Text] [Related]
18. The β-Blocker Esmolol Restores the Vascular Waterfall Phenomenon After Acute Endotoxemia.
Du W; Liu D; Long Y; Wang X
Crit Care Med; 2017 Dec; 45(12):e1247-e1253. PubMed ID: 28991824
[TBL] [Abstract][Full Text] [Related]
19. The influence of esmolol on septic shock and sepsis: A meta-analysis of randomized controlled studies.
Liu P; Wu Q; Tang Y; Zhou Z; Feng M
Am J Emerg Med; 2018 Mar; 36(3):470-474. PubMed ID: 29269160
[TBL] [Abstract][Full Text] [Related]
20. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
Kimmoun A; Louis H; Al Kattani N; Delemazure J; Dessales N; Wei C; Marie PY; Issa K; Levy B
Crit Care Med; 2015 Sep; 43(9):e332-40. PubMed ID: 25962080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
